menu
    • menu

    Company profile for Mythic Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mythic Therapeutics is a product-platform company that is pioneering a powerful new approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Our technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. At Mythic, we focus on patient-centered scienc...
    Mythic Therapeutics is a product-platform company that is pioneering a powerful new approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Our technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. At Mythic, we focus on patient-centered science and are driven to leave a lasting impact on cancer care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mythic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Beaver Street, Waltham, MA 02453
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mythictx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mythic-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mythic Therapeutics Runs Out Of Options, Shuts Down Only Trial
    Mythic Therapeutics Runs Out Of Options, Shuts Down Only Trial

    17 Dec 2025

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    17 Dec 2025
    Share Share
    Mythic Therapeutics Presents Efficacy Data for MYTX-011 at ASCO
    Mythic Therapeutics Presents Efficacy Data for MYTX-011 at ASCO

    31 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250531770472/en/Mythic-Therapeutics-Presents-Compelling-Efficacy-Data-from-its-Phase-1-KisMET-01-Study-Supporting-Best-in-Class-Potential-of-Novel-cMET--ADC-MYTX-011-in-Non-Small-Cell-Lung-Cancer-at-the-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

    BUSINESSWIRE
    31 May 2025
    Share Share
    Mythic Therapeutics to Present Efficacy Data from KisMET-01 Study
    Mythic Therapeutics to Present Efficacy Data from KisMET-01 Study

    22 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522256178/en/Mythic-Therapeutics-to-Present-Compelling-Efficacy-Data-from-Phase-1-KisMET-01-Study-Supporting-Best-in-Class-Potential-of-Investigational-cMET-ADC-MYTX-011-in-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    22 May 2025
    Share Share
    Mythic Therapeutics to Present Updated Data at 2025 ASCO Meeting
    Mythic Therapeutics to Present Updated Data at 2025 ASCO Meeting

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501261347/en/Mythic-Therapeutics-to-Present-Updated-Dose-Escalation-Data-from-Phase-1-KisMET-01-Study-on-MYTX-011-at-the-2025-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

    BUSINESSWIRE
    01 May 2025
    Share Share
    Mythic Therapeutics Shows MYTX-011 Efficacy at AACR Meeting
    Mythic Therapeutics Shows MYTX-011 Efficacy at AACR Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428316979/en/Mythic-Therapeutics-Presents-Preclinical-Data-Demonstrating-Potent-Efficacy-of-MYTX-011-Across-a-Broad-Range-of-Tumor-Xenograft-Models-Harboring-Clinically-Relevant-Mutations-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Mythic's MYTX-011 Initial Dose Escalation Data At ASCO 2024
    Mythic's MYTX-011 Initial Dose Escalation Data At ASCO 2024

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603700748/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search